O’Melveny represented Viva Biotech on the listing Viva Biotech (1873.HK) executed its $194 million initial public offering and listing on the Main Board of the Hong…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
